Showing results (201-210 of 353) with videos related to

Sort By:
Pageof 36
Molecular and Cellular Biochemistry|November 8, 1995
A role for cAMP in angiotensin II mediated inhibition of cell growth in AT1A receptor-transfected CHO-K1 cellsT J Thekkumkara, J Du, C Zwaagstra, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 9, 2004
Adenosine acts through A2 receptors to inhibit IL-2-induced tyrosine phosphorylation of STAT5 in T lymphocytes: role of cyclic adenosine 3',5'-monophosphate and phosphatasesHong Zhang, David M Conrad, Jared J Butler, et al.
Endocrinology|June 1, 1992
Angiotensin-II-binding sites on hepatocyte nucleiG W Booz, K M Conrad, A L Hess, et al.
The Australian and New Zealand Journal of Psychiatry|May 21, 2010
Distinguishing suicidal from non-suicidal deliberate self-harm events in women with Borderline Personality DisorderGillian R Maddock, Gregory L Carter, Elizabeth R Murrell, et al.
Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists|January 1, 1992
Hooper Visual Organization Test performance in lateralized brain injuryA G Fitz, P M Conrad, D L Hom, et al.
Apoptosis : an International Journal on Programmed Cell Death|January 23, 2010
The Ca(2+) channel blocker flunarizine induces caspase-10-dependent apoptosis in Jurkat T-leukemia cellsDavid M Conrad, Suzanne J Furlong, Carolyn D Doucette, et al.
Evaluation Review|March 18, 2010
Validation of the Crime and Violence Scale (CVS) against the Rasch measurement model including differences by gender, race, and ageKendon J Conrad, Barth B Riley, Karen M Conrad, et al.
Applied Ergonomics|October 31, 2006
Designing ergonomic interventions for emergency medical services workers--part III: Bed to stairchair transfersSteven A Lavender, Karen M Conrad, Paul A Reichelt, et al.
Evaluation Review|August 16, 2015
Validation of the Full and Short-Form Self-Help Involvement Scale Against the Rasch Measurement ModelKaren M Conrad, Kendon J Conrad, Lora L Passetti, et al.
The American Journal of Managed Care|October 9, 2012
Expenditures for medicaid patients treated with exenatide compared with other diabetes management regimensJennie H Best, John A Romley, Dana P Goldman, et al.
Pageof 36